Minirin Melt (Desmopressin)

Desmopressin, the active ingredient in Minirin Melt, is a vasopressin analog presented as a 200 µg sublingual melt (tablet) for sublingual use. It treats central diabetes insipidus, primary nocturnal enuresis, nocturnal polyuria, and bleeding disorders such as hemophilia A and von Willebrand disease. GNH USA supplies Minirin Melt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin is used to manage conditions related to antidiuretic hormone deficiency or bleeding disorders. - Central diabetes insipidus: reduces excessive urine output by increasing water reabsorption. - Primary nocturnal enuresis (nocturnal polyuria): decreases nighttime urine volume, helping control bedwetting. - Bleeding disorders (e.g., hemophilia A, von Willebrand disease): raises plasma factor VIII and von Willebrand factor levels to improve hemostasis.

Desmopressin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate pain in the head. - Nasal congestion: sensation of a blocked nose. - Nausea: feeling of stomach upset. - Mild hyponatremia: low sodium levels causing fatigue or mild confusion.

Serious or Rare Side Effects: - Severe hyponatremia: rapid sodium drop that can lead to seizures or coma. - Thrombotic events: formation of blood clots, especially in high‑risk patients. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

Before initiating therapy, consider the following safety measures. - Dose adjustment: required in patients with renal impairment or the elderly. - Fluid restriction: limit excessive water intake to reduce hyponatremia risk. - Monitor electrolytes: regular serum sodium checks during treatment. - Cardiovascular disease: use cautiously in patients with heart failure or hypertension. - Pregnancy and lactation: safety not established; avoid unless clearly needed. - Store at ambient temperature: keep below 25 °C in the original pack, protect from moisture.

Desmopressin can interact with several drug classes; awareness helps prevent complications.

Major Interactions (Avoid): - MAO inhibitors: may potentiate antidiuretic effect leading to severe hyponatremia. - Carbamazepine: can reduce desmopressin efficacy by increasing renal clearance. - NSAIDs: may enhance water retention and increase hyponatremia risk.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): desmopressin may augment hemostatic effect; monitor clotting parameters. - Diuretics (especially thiazides): additive effect on sodium balance; monitor electrolytes. - SSRIs: combined risk of hyponatremia; observe serum sodium levels.